YGYong Gao

Yong Gao

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Yong Gao has a total of 51 co-authors. Here are the top co-authors by number of shared publications:

  • Tuantuan Li

    Department of Clinical Laboratory, The Second People’s Hospital of Fuyang City

    5 shared publications
  • Xiaowu Wang

    Department of Clinical Laboratory, The Second People’s Hospital of Fuyang City

    4 shared publications
  • Lichang Chen

    Department of Clinical Laboratory, The Second People’s Hospital of Fuyang City, Fuyang, Anhui, People’s Republic of China

    2 shared publications
  • Mei Li

    Department of Clinical Laboratory, The Second People’s Hospital of Fuyang City

    2 shared publications
  • Yan Liu

    Department of Clinical Laboratory, The Second People's Hospital of Fuyang City, Fuyang Infectious Disease Clinical College of Anhui Medical University, China

    2 shared publications
  • Yunyun Ding

    Department of Clinical Laboratory, The Second People’s Hospital of Fuyang City

    2 shared publications

Latest Publications

  • Open Access

    A three-phase epidemiological fluctuation framework of extrapulmonary tuberculosis in Fuyang, China: a retrospective study

    by Tuantuan Li, Xiaowu Wang, Mei Li, Yunyun Ding, Yong Gao, Yan Liu

    Objective: This study characterized eight-year epidemiological and clinical features, diagnostic performance, and drug resistance of EPTB in Fuyang, China, and proposed a framework to interpret its dynamic burden. Methods: We conducted a retrospective study of EPTB patients at Fuyang Second People’s Hospital from January 2018 to December 2025. Demographic, clinical, and laboratory data were extracted from medical records. Descriptive statistics and chi-square tests were used to analyze epidemiological characteristics. Diagnostic yields of IGRA, GeneXpert MTB/RIF Ultra, and culture were compared based on positivity rates. Drug susceptibility testing (DST) was performed on culture-positive isolates. MDR was defined as resistance to at least isoniazid and rifampicin. Results: EPTB accounted for 28.46% (2,281/8015) of all tuberculosis (TB) cases. The majority of patients were aged (≥50 years, 52.78%), male (70.45%), and farmers (70.50%). Temporal analysis revealed a distinctive fluctuation pattern, with EPTB cases predominantly concentrated in 2019–2021 and 2024, which we interpret as reflecting a three-phase fluctuation framework. The most prevalent subtypes of EPTB were pleural TB (60.50%), osteoarticular TB (12.98%), lymphatic TB (6.97%), central nervous system (4.65%), and gastrointestinal TB (3.24%). IGRA showed the highest positivity rate (88.04%), significantly higher than GeneXpert MTB/RIF Ultra (35.60%) and culture (14.53%) ( p < 0.001). Clinical characteristics differed across the five most common EPTB subtypes. Among the 54 isolates that underwent DST, resistance rates were highest for isoniazid (14.81%) and ethambutol (11.11%). Overall, 83.33% of these tested isolates were fully susceptible, while 9.26% were multidrugresistant (MDR), accounting for 55.60% of all resistant cases within this tested subset. Conclusion: EPTB constitutes a significant burden, particularly among aged, male, and farming populations. Pleural TB is the most common form, and IGRA offers superior detection yield. Notably, the 2018–2025 EPTB proportion fluctuations fit a three-phase descriptive framework (diagnosis-driven ascendancy, pandemic disruption, re-equilibration), inspired by Omran’s theory as a heuristic analogy, with breakpoints based on annual trends rather than statistically derived. Although overall drug resistance was low among the tested isolates, the presence of MDR cases in this selected sample underscores the importance of routine DST; however, larger unselected studies are warranted to validate the true population-level MDR burden.

  • Open Access

    LASSO regression-based nomogram for distinguishing nontuberculous mycobacterial pulmonary disease from pulmonary tuberculosis: a clinical risk prediction model

    by Wei Zhang, Tuantuan Li, Haiqing Liu, Xiaoyu Cao, Hao Yan, Yong Gao

    This study aims to identify predictive factors that can effectively distinguish between non-tuberculous mycobacterial pulmonary disease (NTM-PD) and pulmonary tuberculosis (PTB) by comparing their clinical characteristics and laboratory indicators, and to construct a risk prediction model based on these factors to improve the accuracy of clinical diagnosis, optimize treatment strategies, and reduce the risks of misdiagnosis and drug resistance. Data from 150 hospitalized patients treated at The Second People’s Hospital of Fuyang City between January 2021 and December 2022 were collected, including 50 cases with NTM-PD and 100 cases with PTB. By gathering clinical data and laboratory inflammation markers of the patients, key predictive factors were identified using LASSO regression. These factors were further analyzed through univariate and multivariate logistic regression analysis to determine the influencing factors of NTM-PD, thereby constructing a nomogram prediction model. The accuracy of the model was evaluated through calibration curves, ROC curves, and Hosmer-Lemeshow goodness-of-fit tests, while its clinical utility was assessed using decision curve analysis and clinical impact curves.The two groups showed significant differences in age, BMI, bronchiectasis, and lung cavitation (P < 0.05). LASSO regression analysis identified age, BMI, bronchiectasis, and lung cavitation as four key variables. Multivariate logistic regression analysis revealed that old age, bronchiectasis, and lung cavitation were risk factors for NTM-PD, while low BMI acted as a protective factor. The nomogram model constructed based on these four variables demonstrated excellent predictive performance. The Hosmer-Lemeshow goodness-of-fit test indicated good model fit (P = 0.448), with an area under the ROC curve (AUC) of 0.861 (95% CI: 0.798–0.923). Decision curve and clinical impact curve analyses suggested that the model has the potential to optimize clinical decision-making within a threshold probability range of 0.05 to 0.75. By analyzing the critical differential characteristics between NTM-PD and PTB, we successfully developed a prediction model based on age, BMI, bronchiectasis, and lung cavitation, which effectively assesses the risk of NTM-PD occurrence, providing clinicians with a practical diagnostic aid.


  • Open Access

    Disease spectrum of patients with hospital-acquired multidrug-resistant organism infections in the intensive care unit: a retrospective study

    by Xiaowu Wang, Yan Liu, Yunyun Ding, Mei Li, Yong Gao, Tuantuan Li

    Objective: To understand the infection status and disease spectrum distribution of patients with hospital-acquired Multidrug-resistant Organism (MDRO) Infections in an intensive care unit (ICU) before, during, and after the Coronavirus Disease 2019 (COVID-19) Pandemic, and provide a basis for the prevention and control of hospital-acquired MDRO infections.Methods: Data from the Second People’s Hospital of Fuyang City’s ICU was analyzed from three periods: pre-COVID-19 (January 1, 2018-December 8, 2019), during COVID-19 (December 9, 2019-December 7, 2022), and post-COVID-19 (December 8, 2022-December 31, 2023). The study compares the disease spectrum of MDRO infections patients across these periods.Results: The incidence density of hospital-acquired MDRO infections showed significant variation over the six-year period, with the highest density in the post-COVID-19 period (43.98 per 1,000 ICU days) and the lowest during the COVID-19 period (21.96 per 1,000 ICU days). The mortality rate associated with MDRO infections was minimized during the COVID-19 pandemic (2.70 per 1,000 ICU days) and rebounded in the post-COVID-19 period (10.66 per 1,000 ICU days). The infection rate of Acinetobacter baumannii (A. baumannii) increased in the post-COVID-19 group compared to the pre-COVID-19 and during-COVID-19 groups (χ2 = 8.82, p = 0.012). Respiratory diseases consistently ranked first pre-, during, and post-COVID-19 pandemic. The proportion of nervous system diseases in the post-COVID-19 group was lower than in the pre-COVID-19 and during COVID-19 groups (p < 0.05), while the proportions of respiratory diseases and acute abdomen were higher than in the pre-COVID-19 and during-COVID-19 groups (p < 0.05). Among ICU MDRO patient death cases, the proportion of respiratory diseases in the post-COVID-19 group was higher than in the pre-COVID-19 and during-COVID-19 groups (p < 0.05).Conclusion: Our data show the mortality rate of hospital-acquired MDRO infections decreased during COVID-19 and increased after restrictions eased. The disease spectrum of MDRO-infected patients is complex and diverse. Standardized, accurate treatment and focused management of respiratory diseases are essential, along with strengthened infection prevention measures.


  • Open Access

    Uremic syndrome with newly diagnosed HIV infection: reflections on a particular case

    by Xiaowu Wang, Dong Wu, Tuantuan Li, Yong Gao

    Introduction: Diagnosis with Western blot test (WB) may not provide clear results for certain patients, including those who are not infected with human immunodeficiency virus (HIV) but produce non-specific reactions, individuals in the HIV window period (WP), those with acute HIV infection, and advanced acquired immunodeficiency syndrome (AIDS) patients. HIV-positive individuals face an elevated risk of developing kidney disease. HIV peritoneal dialysis patients may be more susceptible to catheter-related infections. This study reports a case of HIV detected during early development of a nephrotic syndrome into uremic syndrome. Case presentation: A 46-year-old male individual diagnosed with stage 5 chronic kidney disease was admitted to the hospital in preparation for his first renal replacement therapy. During routine check-ups, the patient was identified as having a reactive response to the HIV antigen/antibody test. The rapid detection results exhibited a weak reaction across all manufacturers, while the enzyme-linked immunosorbent assay (ELISA) test (Bio-Rad, Hercules, USA) showed a reactive response. Nonetheless, the third and fourth generation tests did not yield a response, suggesting that the patient`s internal concentration of HIV antigen or antibody was relatively low at the time. However, the confirmation test did not provide conclusive results, leading the patient to decline further renal replacement therapy. Two months later, the patient`s HIV antigen/antibody levels were measured as 95.23 in the outpatient department of our hospital. Conclusions: This case underscores the importance of actively exploring various detection strategies to enhance the efficiency of detecting acute phase HIV infection during the testing process.

  • Open Access

    Clinical Characteristics of Patients with Nontuberculous Mycobacterium Pulmonary Disease in Fuyang, China: A Retrospective Study

    by Xiaowu Wang, Tuantuan Li, Yan Liu, Yilang Zhu, Lichang Chen, Yong Gao

    Objective: We retrospectively review consecutive patients with nontuberculous mycobacterium (NTM) pulmonary disease reported from a designated hospital for infectious diseases in the Fuyang district of China to determine the clinical characteristics of these patients. Methods: This research enrolled 234 patients with NTM pulmonary disease between January 2018 and May 2023 in the Fuyang district of China. Data were collected from the electronic medical records. The NTM strain composition and clinical characteristics of NTM pulmonary disease were retrospectively analyzed. Results: 73 (31.20%) patients had previous tuberculosis (TB) or TB exposure history and bronchiectasis. Mixed NTM infection accounted for 12.39%. Mycobacterium intracellulare strain was detected in 132 patients (49.62%). Women were found to be more affected by Mycobacterium avium infection, and men by Mycobacterium abscessus infection. Mycobacterium avium (34.21%) and Mycobacterium abscessus (33.33%) strains were most common in people with previous TB or TB exposure history. Among respiratory tract-related diseases, patients with bronchiectasis had the highest isolation rate of Mycobacterium avium (55.36%). Women were susceptible to bronchiectasis (P < 0.01). The median of mononuclear-to-lymphocyte ratio (MLR) was higher in men than in women (P < 0.01). The serum albumin (ALB) level was lower in patients with TB or TB exposure history than in those without TB history (P = 0.034). The prognostic nutritional index (PNI) was lower in patients with TB or TB exposure history than in those without tuberculosis history (P = 0.021). Patients with NTM lung disease were poorly treated. Conclusion: Clinical symptoms of the disease were not species-specific. Mycobacterium intracellulare and Mycobacterium avium strains were predominant in the Fuyang district of China. Previous TB or TB exposure history immensely enhanced the risk of NTM disease.


  • Open Access

    Cerebral Endothelial CXCR2 Promotes Neutrophil Transmigration into Central Nervous System in LPS-Induced Septic Encephalopathy

    by Fengjiao Wu, Yuhong Han, Qianqian Xiong, Haitao Tang, Jing Shi, Qingqing Yang, Xuemeng Li, Haoxuan Jia, Jun Qian, Yishu Dong, et al.

    Septic encephalopathy (SE) represents a severe inflammatory syndrome linked to elevated septic mortality rates, lacking specific therapeutic interventions, and often resulting in enduring neurological sequelae. The present investigation endeavors to elucidate the involvement of C-X-C Motif Chemokine Receptor 2 (CXCR2) in the pathogenesis of SE and to explore the potential of CXCR2 modulation as a therapeutic avenue for SE. Employing a murine SE model induced by lipopolysaccharide (LPS) administration, CXCR2 knockout mice and the CXCR2 inhibitor SB225002 were utilized to assess neutrophil recruitment, endothelial integrity, and transendothelial migration. Our findings substantiate that either CXCR2 deficiency or its inhibition curtails neutrophil recruitment without impacting their adhesion to cerebral endothelial cells. This phenomenon is contingent upon endothelial CXCR2 expression rather than CXCR2’s presence on neutrophils. Furthermore, the CXCR2 blockade preserves the integrity of tight junction protein ZO-1 and mitigates F-actin stress fiber formation in cerebral endothelial cells following septic challenge. Mechanistically, CXCL1-mediated CXCR2 activation triggers cerebral endothelial actin contraction via Rho signaling, thereby facilitating neutrophil transmigration in SE. These observations advocate for the potential therapeutic efficacy of CXCR2 inhibition in managing SE.


  • Open Access

    High expression of TBRG4 in relation to unfavorable outcome and cell ferroptosis in hepatocellular carcinoma

    by Shanchun Tao, Di Cui, Huimin Cheng, Xiaofei Liu, Zhaobin Jiang, Hongwei Chen, Yong Gao

    Background: Hepatocellular carcinoma (HCC) is the most common type of malignant liver tumor with poor prognosis. In this study, we investigated the expression of transforming growth factor beta regulator 4 (TBRG4) in HCC and its effects on the proliferation, invasion, and metastasis of HCC cells, and analyzed the possible molecular mechanisms. Method: Downloading the expression and clinical information of HCC samples in the TCGA database, analyzing the expression differences of TBRG4 by bioinformatics methods, analyzing the clinical relevance and prognostic significance. Performing GO, KEGG and GSEA enrichment analysis on the TBRG4-related gene set in patient HCC tissues. Applying cell counting, scratch test and Transwell experiment to study the biological function of TBRG4 in HCC. Mitochondrial membrane potential, apoptosis and ROS levels were evaluated to assess cell iron death. Western blot, RT-PCR, laser confocal microscopy and co-immunoprecipitation were used to detect and analyze the downstream signaling pathways and interacting molecules of TBRG4. Results: Bioinformatics analysis revealed that TBRG4 was abnormally highly expressed in HCC tumor tissues and was associated with poor prognosis and metastasis in HCC patients. GO and KEGG functional enrichment analysis showed that TBRG4 was related to oxidative stress and NADH dehydrogenase (ubiquinone) activity. GSEA enrichment analysis showed that TBRG4 was associated with Beta catenin independent wnt signaling and B cell receptor. Functional experiments confirmed that knocking down TBRG4 could inhibit the proliferation, migration, and invasion of HCC cells. Mechanistically, TBRG4 inhibited the function of HCC cells through the DDX56/p-AKT/GSK3β signaling pathway. In addition, interference with TBRG4 expression could reduce the mitochondrial membrane potential and accumulate ROS in HCC cells, leading to increased ferroptosis. Co-IP analysis showed that TBRG4 specifically bound to Beclin1. Conclusion: TBRG4 is highly expressed in HCC tumor tissues and is associated with poor prognosis. It may regulate the proliferation, invasion, and metastasis of HCC cells through the DDX56/p-AKT/GSK3β signaling pathway. TBRG4 may interact with Beclin1 to regulate the ferroptosis of HCC cells.


  • Open Access

    Construction of the model for predicting prognosis by key genes regulating EGFR-TKI resistance

    by Jinke Zhuge, Xiuqing Wang, Jingtai Li, Tongyuan Wang, Hongkang Wang, Mingxing Yang, Wen Dong, Yong Gao

    Background: Previous studies have suggested that patients with lung adenocarcinoma (LUAD) will significantly benefit from epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKI). However, many LUAD patients will develop resistance to EGFR-TKI. Thus, our study aims to develop models to predict EGFR-TKI resistance and the LUAD prognosis.Methods: Two Gene Expression Omnibus (GEO) datasets (GSE31625 and GSE34228) were used as the discovery datasets to find the common differentially expressed genes (DEGs) in EGFR-TKI resistant LUAD profiles. The association of these common DEGs with LUAD prognosis was investigated in The Cancer Genome Atlas (TCGA) database. Moreover, we constructed the risk score for prognosis prediction of LUAD by LASSO analysis. The performance of the risk score for predicting LUAD prognosis was calculated using an independent dataset (GSE37745). A random forest model by risk score genes was trained in the training dataset, and the diagnostic ability for distinguishing sensitive and EGFR-TKI resistant samples was validated in the internal testing dataset and external testing datasets (GSE122005, GSE80344, and GSE123066).Results: From the discovery datasets, 267 common upregulated genes and 374 common downregulated genes were identified. Among these common DEGs, there were 59 genes negatively associated with prognosis, while 21 genes exhibited positive correlations with prognosis. Eight genes (ABCC2, ARL2BP, DKK1, FUT1, LRFN4, PYGL, SMNDC1, and SNAI2) were selected to construct the risk score signature. In both the discovery and independent validation datasets, LUAD patients with the higher risk score had a poorer prognosis. The nomogram based on risk score showed good performance in prognosis prediction with a C-index of 0.77. The expression levels of ABCC2, ARL2BP, DKK1, LRFN4, PYGL, SMNDC1, and SNAI2 were positively related to the resistance of EGFR-TKI. However, the expression level of FUT1 was favorably correlated with EGFR-TKI responsiveness. The RF model worked wonderfully for distinguishing sensitive and resistant EGFR-TKI samples in the internal and external testing datasets, with predictive area under the curves (AUC) of 0.973 and 0.817, respectively.Conclusion: Our investigation revealed eight genes associated with EGFR-TKI resistance and provided models for EGFR-TKI resistance and prognosis prediction in LUAD patients.


  • Open Access

    Detection of serum KL-6 and SARS-CoV-2 antibody in patients with coronavirus disease 2019 and the diagnostic value in severe disease

    by Huiyan Wang, Lichang Chen, Yang Zhang, Long Liu, Meimei Xu, Yong Gao, Ming Li

    Background Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a significant threat to human health, but its clinical manifestations vary greatly among individuals. Early detection and treatment are important for severely ill patients to improve their prognosis and reduce the risk of death. Methods In the present study, serum markers were detected and analyzed in moderately ill and severely ill patients. Results The results found that there were statistically significant differences in age, serum Krebs von den Lungen-6 (KL-6) and Immunoglobulin A (IgA) levels between severely ill patients and moderately ill patients (P < 0.05). The cut-off of using KL-6 alone for the diagnosis of severely ill patients was 298.91 U/mL, with an AUC of 0.737, a sensitivity of 100%, and a specificity of 43%. When the diagnosis was performed using KL-6 in combination with Interleukin-6 (IL-6), an indicator of infection, the AUC was 0.776, with a sensitivity and specificity of 82% and 69%, respectively. When the three above were used in combination for diagnosis, the AUC was 0.785, and the sensitivity and specificity were 100% and 59%, respectively. After rehabilitation, the serum levels of KL-6, C-reactive protein (CRP), as well as antibodies, IgA, IgM and IgG, were significantly lower than those in the early stage of hospitalization. Conclusion In the present study, KL-6 and IgA were found to have some diagnostic efficacy for severely ill patients with COVID-19, but larger cohort studies are still needed for further confirmation, which in turn improves the diagnostic and therapeutic efficiency of severely ill patients.


  • Open Access

    Evaluation of the auxiliary diagnosis value of antibodies assays for the detection of novel coronavirus (SARS-Cov-2)

    by Gao Yong, Yuan Yi, Li Tuantuan, Wang Xiaowu, Li Xiuyong, Li Ang, Han Mingfeng

    Background: The spread of an novel coronavirus (SARS-CoV-2, previously named 2019-nCoV) has already taken on pandemic proportions, affecting over 100 countries in a matter of weeks. Elucidating the diagnostic value of different methods, especially the auxiliary diagnosis value of antibodies assays for SARS-CoV-2 infection is helpful for improving the sensitivities of pathogenic-diagnosis, providing timely treatment, and differentiating the infected cases from the healthy, thus preventing further epidemics. Methods: Medical records from 38 patients with confirmed SARS-CoV-2 infection in the Second People’s Hospital of Fuyang from January 22, 2020 to February 28, 2020 were collected and retrospectively analyzed. Specimens including throat swabs, sputum and serum were collected during the hospitalization period, viral RNAs and serum IgM-IgG antibodies to SARS-CoV-2 were measured respectively. The detectability of different methods as well as the auxiliary diagnosis value of antibodies test for SARS-CoV-2 infection were analyzed. Results: Among 38 patients, the total seropositive rate for IgM and IgG was 50.0% and 92.1%, respectively. Two patients remained seronegative throughout the course of illness. In the early phase of illness, the RNA test for sputum specimens possessed the highest detectability(92.3%), followed by the the RNA test for throat swabs (69.2%), and the antibodies assays presented lower positive rates(IgM, 23.0%, IgG, 53.8%). While, the sensitivity of antibodies assays overtook that of RNA test since day 8 after onset (IgM, 50.0%; IgG, 87.5%). Of note, the positive rate of throat swabs was only 13.0% for cases in later phase(≥15 d.a.o), and the sensitivities of IgM and IgG rose to 52.2% and 91.3%, respectively. Combined use of antibodies assay and qRT-PCR at the same time was able to improve the sensitivities of pathogenic-diagnosis, especially for the throat swabs group at the later stage of illness. Moreover, most of these cases with undetectable viral RNA in throat swabs specimens at the early stage of illness were able to be IgM/IgG seropositive after 7 days. Conclusions: The antibodies detection against SARS-CoV-2 offers vital clinical information for physicians, and could be used as an effective supplementary indicator for suspected cases of negative viral nucleic acid detection or in conjunction with nucleic acid detection in the diagnosis of suspected cases.